Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for MGNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 63.65M
March 31, 2026 63.56M
December 31, 2025 63.32M
September 30, 2025 63.26M
June 30, 2025 63.21M
March 31, 2025 63.09M
December 31, 2024 62.82M
September 30, 2024 62.76M
June 30, 2024 62.72M
March 31, 2024 62.56M
December 31, 2023 62.07M
September 30, 2023 62.03M
June 30, 2023 61.94M
March 31, 2023 61.84M
December 31, 2022 61.70M
September 30, 2022 61.46M
June 30, 2022 61.46M
March 31, 2022 61.33M
December 31, 2021 61.31M
September 30, 2021 61.25M
June 30, 2021 60.13M
March 31, 2021 60.01M
December 31, 2020 56.24M
September 30, 2020 56.17M
June 30, 2020 53.36M
Date Value
March 31, 2020 49.13M
December 31, 2019 48.96M
September 30, 2019 48.91M
June 30, 2019 48.89M
March 31, 2019 48.80M
December 31, 2018 42.35M
September 30, 2018 42.25M
June 30, 2018 42.23M
March 31, 2018 37.02M
December 31, 2017 36.86M
September 30, 2017 36.81M
June 30, 2017 36.68M
March 31, 2017 34.98M
December 31, 2016 34.87M
September 30, 2016 34.81M
June 30, 2016 34.69M
March 31, 2016 34.54M
December 31, 2015 34.35M
September 30, 2015 34.25M
June 30, 2015 30.12M
March 31, 2015 30.02M
December 31, 2014 28.00M
September 30, 2014 27.77M
June 30, 2014 27.72M
March 31, 2014 27.50M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Gilead Sciences, Inc. 1.241B
Xencor, Inc. 74.33M
ACADIA Pharmaceuticals, Inc. 172.13M
Alnylam Pharmaceuticals, Inc. 133.73M
Anika Therapeutics, Inc. 13.38M